ABC News’ Phil Lipof speaks with law professor Anya Prince on how 23andMe’s recent layoffs and shuttering of its drug ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

In the year since its hack, 23andMe has lost all of its value and most of its governing board — and somehow, things just keep ...